Current Status and Future Direction of Multi-targeted Drugs 
in the Era of Personalized Therapy
—Overview of Advances in Multi-targeted Therapy in Non-small Cell Lung Cancer

Current Status and Future Direction of Multi-targeted Drugs 
in the Era of Personalized Therapy
—Overview of Advances in Multi-targeted Therapy in Non-small Cell Lung Cancer

Multi-targeted tyrosine kinase inhibitors (TKIs) play important roles in the treatment of non-small cell lung cancer (NSCLC). Recently, results of several large phase III studies have been published, showing bittersweet efficacy of multi-targeted TKIs. In the era of personalized therapy, optimal use...

Full description

Bibliographic Details
Main Author: Caicun ZHOU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Multi-targeted tyrosine kinase inhibitor
Sunitinib
Sorafenib
Vandetanib
Crizotinib
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2011.11.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2011.11.08

Similar Items